Interpace Diagnostics Group Inc (NASDAQ:IDXG)

0.90
Delayed Data
As of May 18
 +0.0245 / +2.80%
Today’s Change
0.72
Today|||52-Week Range
2.65
-11.76%
Year-to-Date
No recent news for Interpace Diagnostics Group Inc.

Today’s Trading

Previous close0.88
Today’s open0.88
Day’s range0.88 - 0.90
Volume130,964
Average volume (3 months)441,401
Market cap$26.8M
Data as of 4:00pm ET, 05/18/2018

Growth & Valuation

Earnings growth (last year)+85.43%
Earnings growth (this year)+70.37%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+21.49%
P/E ratioNM
Price/Sales1.01
Price/Book0.67

Competitors

 Today’s
change
Today’s
% change
BMRABiomerica Inc+0.02+0.54%
TRILTrillium Therapeutic...+0.30+5.00%
APHBAmpliPhi Biosciences...+0.03+2.63%
GALTGalectin Therapeutic...+0.18+4.11%
Data as of 6:30pm ET, 05/18/2018

Financials

Next reporting dateAugust 15, 2018
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$15.9M
Annual profit (last year)-$12.2M
Net profit margin-80.12%

Profile

Sector
Health Services
Industry
Services to the Health Industry
President, Chief Executive Officer &
Director
Jack E. Stover
Senior Vice President-
Operations
Glenn Gershon
Corporate headquarters
Parsippany, New Jersey

Forecasts